Form 4: Dolby Laboratories Executive Exercises and Sells Shares Under Pre-Arranged 10b5-1 Plan

Mark Andrew Sherman, EVP, General Counsel & Secretary of Dolby Laboratories, Inc., executed a pre-arranged transaction on June 4, 2025, exercising stock options and simultaneously selling an equivalent number of Class A Common Stock shares.

Summary

• Mark Andrew Sherman, an EVP, General Counsel & Secretary at Dolby Laboratories, Inc. (DLB), reported transactions on June 4, 2025.
• The transactions were conducted under a Rule 10b5-1(c) plan, indicating a pre-scheduled sale.
• Mr. Sherman exercised 15,000 employee stock options for Class A Common Stock at an exercise price of $64.6 per share.
• Concurrently, he sold 15,000 shares of Class A Common Stock at a weighted average price of $75.0191 per share.
• Following these transactions, Mr. Sherman beneficially owns 62,397 shares of Class A Common Stock, which includes 45,470 shares underlying restricted stock units subject to vesting.
• He also holds 4,500 unexercised employee stock options.
• The exercised options were part of a performance-based award granted for a target of 28,000 shares, with 19,500 shares (75% of target) having vested based on total shareholder return performance criteria ending December 17, 2021.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the executive profited from the option exercise and sale, the transaction was pre-planned under a 10b5-1 plan, which is a routine event for executive liquidity and compensation management and typically does not signal new information about the company's prospects.

Positives

• The executive exercised options at a lower price ($64.6) and sold shares at a higher price ($75.0191), indicating a profitable transaction for the insider.
• The transaction was conducted under a Rule 10b5-1 plan, which suggests a pre-planned and routine liquidity event rather than a reaction to new, non-public information.

Negatives

• Insider selling, even under a 10b5-1 plan, can sometimes be perceived by the market as a lack of confidence, although this is often a routine part of executive compensation and liquidity management.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction and does not provide information relevant to broader industry trends or competitive landscape analysis.

Stakeholder Impact

• The transaction is a routine insider stock option exercise and sale under a pre-arranged plan, which has minimal direct impact on shareholders, employees, customers, suppliers, or creditors beyond standard executive compensation practices.

Key Dates

Keywords

Dolby Laboratories, DLB, SEC Form 4, Insider Trading, Stock Option Exercise, Share Sale, Rule 10b5-1, Executive Compensation, Mark Andrew Sherman, Beneficial Ownership